TY - JOUR T1 - Survival of patients with schistosomiasis-associated pulmonary arterial hypertension in the modern management era JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.00307-2018 VL - 51 IS - 6 SP - 1800307 AU - Caio Julio Cesar Fernandes AU - Bruna Piloto AU - Marcela Castro AU - Francisca Gavilanes Oleas AU - Jose Leonidas Alves, Jr AU - Luis Felipe Lopes Prada AU - Carlos Jardim AU - Rogerio Souza Y1 - 2018/06/01 UR - http://erj.ersjournals.com/content/51/6/1800307.abstract N2 - Pulmonary arterial hypertension (PAH) is a life-threatening disease characterised by an elevated pulmonary vascular resistance in the absence of left ventricular disease, and increasing pulmonary artery pressure, with consequent right ventricular failure and death [1]. Several aetiologies have been associated with PAH, including connective tissue diseases, congenital heart diseases and chronic infections, such as HIV. Due to its high prevalence in developing countries, one of the most relevant forms of PAH worldwide is the one associated to schistosomiasis [2].Survival in schistosomiasis associated pulmonary arterial hypertension has improved in recent years with the use of targeted therapies http://ow.ly/perr30jrhBo ER -